Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
18 Results for "
eating
" in MedChemExpress (MCE) Product Catalog:
Products (18)
18 Results for "eating" in MCE Product Catalog:
2
2 Cited Publications
Art. -Nr.: HY-A0183
CAS. Nr.: 1446756-47-3
Synonyms: Phospholipids, phosphatidylserines; Serine glycerophosphatides
Category:
Target:
1
1 Cited Publications
Target:
Forschungsgebiete:
R-PSOP is highly potent and selective nonpeptidic NMUR2 antagonist. R-PSOP binds to NMUR2 with the Kis of 52 and 32 nM for the human and rat NMUR2, respectively. R-PSOP shows moderate CNS penetration. R-PSOP can be used for the research of the eating disorders, obesity, pain, and stress-related disorders .
Synonyms: ACT-539313
Forschungsgebiete:
Nivasorexant (ACT-539313) is an orally active, blood-brain barrier penetrant, selective orexin OX1R inhibitor. Nivasorexant specifically blocks central OX1Rs without affecting OX2Rs, and exhibits competitive inhibitory activity against CYP2C8, CYP2C9, CYP2C19 and CYP3A4 (IC50 values are 25 μM, 8.6 μM, 1.6 μM, 19 μM/44 μM, respectively). Nivasorexant significantly reduces binge-like eating behavior of highly palatable food in rat models and has long-acting properties. Nivasorexant shows no relevant off-target activity against over 130 selected proteins, exhibits favorable safety profiles, and can be used for studies related to binge eating disorder .
Art. -Nr.: HY-P991023
CAS. Nr.: 2911590-72-0
Synonyms: 6MW3211
Target:
Forschungsgebiete:
Art. -Nr.: HY-P990262
Target:
Forschungsgebiete:
Art. -Nr.: HY-P11097
CAS. Nr.: 3056822-31-9
Target:
Forschungsgebiete:
Art. -Nr.: HY-150191
CAS. Nr.: 2315406-63-2
Target:
Forschungsgebiete:
IMA-1 is an inhibitor that inhibits the interaction between arachidonic acid 12-lipoxygenase (ALOX12) and acetyl-CoA carboxylase 1 (ACC1). IMA-1 significantly blocks the progression of diet-induced non-alcoholic steatohepatitis (NASH) in male mice and crab-eating monkeys, and does not cause hyperlipidemia. IMA-1 can be used for the study of NASH .
Art. -Nr.: HY-159595
CAS. Nr.: 1233353-86-0
Forschungsgebiete:
PCSK9-IN-29 is a lipid-lowering agent. PCSK9-IN-29 can increase low-density lipoprotein receptor (LDLR) protein expression and decrease PCSK9 protein expression in hepG2 cells. PCSK9-IN-29 can reduce the levels of serum LDL-C, TC, and liver enzyme ALT in crab eating macaques fed a high-fat diet, lower body weight and fat, and increase bone mineral content. PCSK9-IN-29 can be used for research on non-alcoholic fatty liver disease and obesity .
Target:
Forschungsgebiete:
Art. -Nr.: HY-153458
CAS. Nr.: 2125735-57-9
Target:
Forschungsgebiete:
Cardiovascular Disease Neurological Disease Metabolic Disease
Orexin receptor modulator-1 is an orexin receptor modulator. Orexin receptor modulator-1 can be used for the research of substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension .
Art. -Nr.: HY-19305
CAS. Nr.: 219517-98-3
Target:
Forschungsgebiete:
EP-51216 is a growth hormone agonist peptide. EP-51216 increases food intake. EP-51216 can be used in the research of eating disorders .
Art. -Nr.: HY-P3677
CAS. Nr.: 102961-52-4
Target:
Forschungsgebiete:
Art. -Nr.: HY-123138
CAS. Nr.: 127414-58-8
Target:
Forschungsgebiete:
LY206130 free base is a 5-HT1A receptor antagonist with the activity of enhancing exogenous serotonin levels. LY206130 free base, when used concomitantly with fluoxetine, may enhance the appetite-suppressing effects of fluoxetine. LY206130 free base was shown to significantly reduce sweetened milk concentrate consumption in a dietary model. Clinical application of LY206130 free base may be beneficial in curbing eating disorders and obesity .
Art. -Nr.: HY-P10041
CAS. Nr.: 938193-98-7
Target:
Forschungsgebiete:
Art. -Nr.: HY-17673
CAS. Nr.: 216319-58-3
Target:
Forschungsgebiete:
PD 168368 derivative-1 (Compound 16) is a derivative of PD 168368 (HY-116216), with Ki values of 0.46 and 3.7 nM for the subtypes of bombesin receptor (BB₁ and BB₂). PD 168368 derivative-1 can be used for the study of various diseases, such as cancer, depression, and eating disorders .
Art. -Nr.: HY-17674
CAS. Nr.: 204067-06-1
Target:
Forschungsgebiete:
Bombesin receptor antagonist-1 (Example 32) is a bombesin receptor antagonist with Ki values for neurotide B (NMB receptor) and gastrin-releasing peptide receptor (GRP receptor) of 0.17 and 20 nM respectively. Bombesin receptor antagonist-1 can be used to study various diseases, such as cancer, depression, and eating disorders .
Art. -Nr.: HY-180465
CAS. Nr.: 616201-56-0
Target:
Forschungsgebiete:
5-HT2C agonist-12 (example.2) is a selective and orally active 5-HT2C receptor agonist. 5-HT2C agonist-12 can inhibit the accumulation of IP3 with an IC50 of 4.5 nM. 5-HT2C agonist-12 can induce a feeling of fullness, shorten the time of eating, and reduce calorie intake. 5-HT2C agonist-12 can be used for the research of obesity .
Art. -Nr.: HY-P992158
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
